Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1997-04-17
1998-05-05
Weddington, Kevin E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514170, 514181, 514182, A61K 3156
Patent
active
057474800
ABSTRACT:
This invention provides a method of contraception which comprises administering to a female of child bearing age for 28 consecutive days,
REFERENCES:
patent: 3957982 (1976-05-01), Lachnit-Fixson et al.
patent: 3969502 (1976-07-01), Lachnit-Fixson
patent: 4390531 (1983-06-01), Edgren
patent: 4530839 (1985-07-01), Pasquale
patent: 4621079 (1986-11-01), Lachnit-Fixson et al.
patent: 4628051 (1986-12-01), Pasquale
patent: 4921843 (1990-05-01), Pasquale
patent: 4962098 (1990-10-01), Boissonneault
patent: 5262408 (1993-11-01), Bergink
patent: 5280023 (1994-01-01), Ehrlich et al.
patent: 5418228 (1995-05-01), Bennink
patent: 5583129 (1996-12-01), Spona et al.
Sartoretto et al., Clinical evaluation of a low dosage estrogen-progesterone association (100.mu.g of d-norgestrel and 20.mu.g
American Home Products Corporation
Milowsky Arnold S.
Weddington Kevin E.
LandOfFree
Oral contraceptive does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oral contraceptive, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral contraceptive will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-54772